Preclinical and clinical pharmacodynamic assessment of L-778,123, a dual inhibitor of farnesyl:protein transferase and geranylgeranyl:protein transferase type-I.

预酸化 外周血单个核细胞 药理学 转移酶 药效学 化学 医学 体外 生物化学 药代动力学
作者
Robert B. Lobell,Dongming Liu,Carolyn A. Buser,Joseph P. Davide,Elizabeth DePuy,Kelly Hamilton,Kenneth S. Koblan,Yih Lee,Scott D. Mosser,Sherri L. Motzel,James L. Abbruzzese,Charles S. Fuchs,Eric K. Rowinsky,Eric H. Rubin,Sunil Sharma,Paul Deutsch,Kathryn Mazina,Briggs Morrison,Lynne Wildonger,Siu-Long Yao,Nancy E. Kohl
出处
期刊:PubMed 卷期号:1 (9): 747-58 被引量:119
链接
标识
摘要

Farnesyl:protein transferase (FPTase) inhibitors were developed as anti-Ras drugs, but they fail to inhibit Ki-Ras activity because Ki-Ras can be modified by geranylgeranyl:protein transferase type-I (GGPTase-I). L-778,123, an inhibitor of FPTase and GGPTase-I, was developed in part because it can completely inhibit Ki-Ras prenylation. To support the clinical development of L-778,123, we developed pharmacodynamic assays using peripheral blood mononuclear cells (PBMCs) to measure the inhibition of prenylation of HDJ2 and Rap1A, proteins that are FPTase- and GGPTase-I substrates, respectively. We validated these assays in animal models and show that inhibition of HDJ2 prenylation in mouse PBMCs correlates with the concentration of FPTase inhibitors in blood. In dogs, continuous infusion of L-778,123 inhibited both HDJ2 and Rap1A prenylation in PBMCs, but we did not detect inhibition of Ki-Ras prenylation. We reported previously results from the first L-778,123 Phase I trial that showed a dose-dependent inhibition of HDJ2 farnesylation in PBMCs. In this report, we present additional analysis of patient samples from this trial and a second Phase I trial of L-778,123, and demonstrate the inhibition of both HDJ2 and Rap1A prenylation in PBMC samples. This study represents the first demonstration of GGPTase-I inhibition in humans. However, no inhibition of Ki-Ras prenylation by L-778,123 was detected in patient samples. These results confirm the pharmacologic profile of L-778,123 in humans as a dual inhibitor of FPTase and GGPTase-I, but indicate that the intended target of the drug, Ki-Ras, was not inhibited.

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
大幅提高文件上传限制,最高150M (2024-4-1)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
oceanao应助Kelly1426采纳,获得10
刚刚
2秒前
纳米完成签到 ,获得积分10
2秒前
入江发布了新的文献求助10
3秒前
tsm发布了新的文献求助10
4秒前
xx关闭了xx文献求助
5秒前
赵峰完成签到,获得积分10
5秒前
哈哈完成签到 ,获得积分10
6秒前
muzi完成签到,获得积分10
6秒前
9秒前
iNk完成签到,获得积分0
10秒前
12秒前
研友_5Z4ZA5完成签到,获得积分10
12秒前
慕青应助夏荧荧采纳,获得10
14秒前
北海完成签到,获得积分10
17秒前
wanci应助mr_wu采纳,获得10
18秒前
liu完成签到 ,获得积分10
18秒前
19秒前
Jouleken完成签到,获得积分10
20秒前
Ava应助Nuyoah采纳,获得10
20秒前
21秒前
zasideler完成签到,获得积分10
23秒前
23秒前
surain发布了新的文献求助10
24秒前
27秒前
lcsolar完成签到,获得积分10
29秒前
咕噜噜完成签到,获得积分10
30秒前
31秒前
风起完成签到 ,获得积分10
32秒前
耍酷的傲白完成签到 ,获得积分10
33秒前
月亮完成签到,获得积分10
33秒前
314gjj完成签到,获得积分10
34秒前
Nuyoah发布了新的文献求助10
34秒前
咕噜噜发布了新的文献求助10
34秒前
mr_wu完成签到,获得积分10
37秒前
soooo关注了科研通微信公众号
37秒前
星辰大海应助科研通管家采纳,获得10
38秒前
苏卿应助科研通管家采纳,获得10
38秒前
我是老大应助科研通管家采纳,获得10
38秒前
苏卿应助科研通管家采纳,获得30
38秒前
高分求助中
Evolution 10000
ISSN 2159-8274 EISSN 2159-8290 1000
Becoming: An Introduction to Jung's Concept of Individuation 600
Ore genesis in the Zambian Copperbelt with particular reference to the northern sector of the Chambishi basin 500
A new species of Coccus (Homoptera: Coccoidea) from Malawi 500
A new species of Velataspis (Hemiptera Coccoidea Diaspididae) from tea in Assam 500
PraxisRatgeber: Mantiden: Faszinierende Lauerjäger 500
热门求助领域 (近24小时)
化学 医学 生物 材料科学 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 基因 遗传学 催化作用 物理化学 免疫学 量子力学 细胞生物学
热门帖子
关注 科研通微信公众号,转发送积分 3162769
求助须知:如何正确求助?哪些是违规求助? 2813685
关于积分的说明 7901577
捐赠科研通 2473296
什么是DOI,文献DOI怎么找? 1316715
科研通“疑难数据库(出版商)”最低求助积分说明 631516
版权声明 602175